Platinum‐containing regimens for triple‐negative metastatic breast cancer
Review (10 studies, n=1,349) reports that for women with metastatic triple‐negative breast cancer, there was moderate‐quality evidence of a small survival benefit from platinum‐based regimens compared to non‐platinum regimens.
Source:
Cochrane Database of Systematic Reviews